Recruiting Kratom Use Disorder Management Using Clonidine and/or Buprenorphine NCT05883358 Conditions Chemically-Induced Disorders, Mental Disorders, Substance Withdrawal Syndrome, +2 more Locations Salem Anaesthesia Pain Clinic — Surrey, British Columbia, Canada View Trial Details
Completed Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Factors. NCT03996096 Conditions Bone Marrow Diseases, Chemically-Induced Disorders, Chronic Disease, +17 more Locations University hospital — Caen, France View Trial Details
Completed Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19 NCT05336656 Conditions ARDS, COVID-19, Chemically-Induced Disorders, +20 more Locations Wilkes University — Wilkes-Barre, Pennsylvania, United States View Trial Details
Completed AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU) NCT04422808 Conditions Chemically-Induced Disorders, Critical Illness, Disease Attributes, +7 more Locations Wilkes University — Wilkes-Barre, Pennsylvania, United States View Trial Details
Completed Early Rehabilitation in Critically Ill Children - The PICU Liber8 Study NCT03573479 Conditions Chemically-Induced Disorders, Confusion, Critical Illness, +16 more Locations McMaster Children's Hospital — Hamilton, Ontario, Canada Children's Hospital London Health Sciences — London, Ontario, Canada View Trial Details
Completed Comparison of the Efficacy of a Protocol for the Withdrawal of Neurosedation From the Usual Strategy in Cerebroses NCT03114904 Conditions Cerebral Lesion, Chemically-Induced Disorders, Mental Disorders, +3 more Locations CHU Amiens Picardie — Amiens, Picardie, France View Trial Details
Completed Protocolized Sedative Weaning VS. Usual Care in Pediatric Critically Ill, RCT NCT03018977 Conditions Chemically-Induced Disorders, Mental Disorders, Substance Withdrawal Syndrome, +2 more Locations Department of Pediatric,Ramathibodi Hospital — Bangkok, Thailand View Trial Details
